Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

SYGNIS Pharma licenses European patent rights to AX-200

Feb. 16, 2011

Medivir begins phase Ia trial of HCV polymerase inhibitor TMC-649128

Feb. 16, 2011

Oxigene and NCI collaborate on phase II Zybrestat trial in ovarian cancer

Feb. 15, 2011

Eisai and Teikoku Seiyaku enter license agreement for transdermal Aricept in Japan

Feb. 14, 2011

Medivir and Janssen enter R&D collaboration for dengue virus infection

Feb. 14, 2011

Alexion acquires investigational therapy for molybdenum cofactor deficiency

Feb. 14, 2011

Intellikine and PKD Foundation collaborate on treatment of polycystic kidney disease

Feb. 14, 2011

Futura Medical and Ansell enter commercialization agreement for PET-500

Feb. 11, 2011

Anacor and Medicis to collaborate on development of acne treatments

Feb. 11, 2011

Cephalon and Alba Therapeutics enter option agreement for larazotide acetate

Feb. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...